Comparative efficacy of sunitinib versus sorafenib as the first-line treatment for patients with metastatic renal cell carcinoma.

被引：0
|
作者：
Park, Seongjoon
Lee, Jae-Lyun
Park, Inkeun
Park, Kwonoh
Ahn, Yongchel
Ahn, Jin-Hee
Lee, Dae Ho
Song, Cheryn
Hong, Jun Hyuk
Kim, Choung-Soo
Ahn, Hanjong
机构：
[1] Univ Ulsan, Coll Med, Dept Oncol, Asan Med Ctr, Seoul, South Korea
[2] Univ Ulsan, Coll Med, Dept Urol, Asan Med Ctr, Seoul, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15080
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Comparative Efficacy of Sunitinib versus Sorafenib as First-Line Treatment for Patients with Metastatic Renal Cell Carcinoma
    Park, Seong Joon
    Lee, Jae-Lyun
    Park, Inkeun
    Park, Kwonoh
    Ahn, Yongcheol
    Ahn, Jin-Hee
    Lee, Dae-Ho
    Ahn, Shin
    Song, Cheryn
    Hong, Jun Hyuk
    Kim, Choung-Soo
    Ahn, Hanjong
    [J]. CHEMOTHERAPY, 2012, 58 (06) : 468 - 474
  • [2] COMPARATIVE EFFICACY OF SUNITINIB VERSUS SORAFENIB AS THE FIRST-LINE TREATMENT FOR PATIENTS WITH METASTATIC RENAL CELL CARCINOMA
    Park, S. J.
    Lee, J.
    Park, I.
    Park, K.
    Ahn, J.
    Lee, D. H.
    Song, C.
    Hong, J. H.
    Kim, C.
    Ahn, H.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 287 - 288
  • [3] Risk of treatment failure after first-line sunitinib therapy in patients with metastatic renal cell carcinoma.
    Chen, Chi-Chang
    Hess, Gregory P.
    Liu, Zhimei
    Gesme, Dean H.
    Agarwala, Sanjiv S.
    Hill, Jerrold W.
    Guo, Min Amy
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [4] Efficacy and safety of sorafenib versus sunitinib as first-line treatment in patients with metastatic renal cell carcinoma: largest single-center retrospective analysis
    Sheng, Xinan
    Chi, Zhihong
    Cui, Chuanliang
    Si, Lu
    Li, Siming
    Tang, Bixia
    Mao, Lili
    Lian, Bin
    Wang, Xuan
    Yan, Xieqiao
    Guo, Jun
    [J]. ONCOTARGET, 2016, 7 (19) : 27044 - 27054
  • [5] Sorafenib versus sunitinib as first-line treatment in metastatic renal cell carcinoma: Largest multicenter retrospective analysis.
    Sheng, Xinan
    Zhang, Hailiang
    Li, Xuesong
    Chi, Zhihong
    He, Zhisong
    Ye, Dingwei
    Guo, Jun
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [6] Economic Evaluation of Everolimus versus Sorafenib for the Treatment of Metastatic Renal Cell Carcinoma after Failure of First-Line Sunitinib
    Casciano, Roman
    Chulikavit, Maruit
    Di Lorenzo, Giuseppe
    Liu, Zhimei
    Baladi, Jean-Francois
    Wang, Xufang
    Robertson, Justin
    Garrison, Lou
    [J]. VALUE IN HEALTH, 2011, 14 (06) : 846 - 851
  • [7] Optimizing axitinib treatment selection following first-line sunitinib in metastatic renal cell carcinoma.
    Bracarda, Sergio
    Bamias, Aristotelis
    Casper, Jochen
    Negrier, Sylvie
    Sella, Avishay
    Staehler, Michael D.
    Tarazi, Jamal Christo
    Felici, Alessandra
    Rosbrook, Brad
    Jardinaud-Lopez, Monica
    Escudier, Bernard
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [8] Efficacy and safety of first-line sunitinib in Chinese patients with metastatic renal cell carcinoma
    Qin, Shu-Kui
    Jin, Jie
    Guo, Jun
    Wang, Jin-Wan
    Zhou, Fang-Dian
    Huang, Yi-Ran
    Ren, Xiu-Bao
    Ye, Ding-Wei
    Pan, Sharon
    Sajben, Peter
    Wang, Qiao
    [J]. FUTURE ONCOLOGY, 2018, 14 (18) : 1835 - 1845
  • [9] EFFICACY AND SAFETY OF SUNITINIB AS FIRST-LINE TREATMENT IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA: SYSTEMATIC REVIEW
    Huerfano, C.
    NinoNino, C. P.
    Davila, F.
    Reyes, J. M.
    Diaz, J. A.
    [J]. VALUE IN HEALTH, 2016, 19 (03) : A169 - A169
  • [10] Axitinib versus sorafenib as first-line therapy in patients with metastatic renal cell carcinoma (mRCC)
    Hutson, Thomas E.
    Gallardo, Jorge
    Lesovoy, Vladmir
    Al-Shukri, Salman
    Stus, Viktor
    Bair, A. H.
    Rosbrook, Brad
    Bycott, Paul W.
    Tarazi, Jamal Christo
    Kim, Sinil
    Vogelzang, Nicholas J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
12345